[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Doc [@DocLW](/creator/twitter/DocLW) on x XXX followers Created: 2025-07-05 23:54:15 UTC Psychedelics DD 🧵 CYBN | Cybin | Mental Health 🟢 Recent substantial fund raising thru equities success bolsters runway, possibly puts them ahead of peers 🟢 Low debt cost, good terms 🟢 XX patents, more otw 🟢 Successful Phase X treatment for Major Depression, now on Phase X ✅ Analysts view positively & retail appears mostly positive 🟢 Notable institutional shares, but not prohibitive to traders 🟢 Partnerships mostly smaller entities except $TMO which is a notable positive factor 🟢 Experienced leadership overall ↔️ Early stage trial treating Generalized Anxiety moving on to Phase X ↔️ Raising $ thru increasing shares helps bring in cash & avoid debt but risks dilution ❓ Leadership lacks experience w big pharma, not sure how significant that is 🚩Dilution a concern using funding thru equities 🚩Much weight placed on X forerunner drugs, a negative result for X could tank the stock $ATAI $MNMD $CMPS XXX engagements  **Related Topics** [debt](/topic/debt) [stocks](/topic/stocks) [mental health](/topic/mental-health) [Post Link](https://x.com/DocLW/status/1941646841520521330)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Doc @DocLW on x XXX followers
Created: 2025-07-05 23:54:15 UTC
Psychedelics DD 🧵
CYBN | Cybin | Mental Health
🟢 Recent substantial fund raising thru equities success bolsters runway, possibly puts them ahead of peers 🟢 Low debt cost, good terms 🟢 XX patents, more otw 🟢 Successful Phase X treatment for Major Depression, now on Phase X ✅ Analysts view positively & retail appears mostly positive 🟢 Notable institutional shares, but not prohibitive to traders 🟢 Partnerships mostly smaller entities except $TMO which is a notable positive factor 🟢 Experienced leadership overall ↔️ Early stage trial treating Generalized Anxiety moving on to Phase X ↔️ Raising $ thru increasing shares helps bring in cash & avoid debt but risks dilution ❓ Leadership lacks experience w big pharma, not sure how significant that is 🚩Dilution a concern using funding thru equities 🚩Much weight placed on X forerunner drugs, a negative result for X could tank the stock
$ATAI $MNMD $CMPS
XXX engagements
Related Topics debt stocks mental health